| 1 |
30668110 | Presentation and Delivery of Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand via Elongated Plant Viral Nanoparticle Enhances Antitumor Efficacy. | 2019 Feb 26 |
2 |
| 2 |
26926590 | TRAIL-CM4 fusion protein shows in vitro antibacterial activity and a stronger antitumor activity than solo TRAIL protein. | 2016 Jun |
1 |
| 3 |
27750195 | An HPLC method associated with a thermodynamic analysis to compare the binding of TRAIL and its nanovectorized form to death receptors DR4 and DR5 and their relationship to cytotoxicity. | 2016 Nov 15 |
2 |
| 4 |
22240897 | Regulation in the targeting of TRAIL receptor 1 to cell surface via GODZ for TRAIL sensitivity in tumor cells. | 2012 Jul |
1 |
| 5 |
20149311 | Calcium/calmodulin-dependent protein kinase II (CaMKII) regulates tumour necrosis factor-related apoptosis inducing ligand (TRAIL)-mediated apoptosis of fibroblast-like synovial cells (FLS) by phosphorylation of Akt. | 2009 Nov-Dec |
1 |
| 6 |
18474604 | DR4-selective tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) variants obtained by structure-based design. | 2008 Jul 18 |
1 |
| 7 |
16891471 | Multiple mechanisms underlie resistance of leukemia cells to Apo2 Ligand/TRAIL. | 2006 Jul |
3 |
| 8 |
14729063 | Low extracellular pH augments TRAIL-induced apoptotic death through the mitochondria-mediated caspase signal transduction pathway. | 2004 Feb 1 |
1 |
| 9 |
12587790 | Adenoviral (full-length) Apo2L/TRAIL gene transfer is an ineffective treatment strategy for malignant glioma. | 2003 Jan |
9 |
| 10 |
11840265 | TRAIL (Apo2L) suppresses growth of primary human leukemia and myelodysplasia progenitors. | 2002 Jan |
6 |